I agree that the effect that Bryo had on the compassionate use patients is the compelling piece of evidence that Bryo works in AZD. Also Dr Alkon's statements on Bryo carry a lot of weight considering his long and distinguished research in AZD. Those are among the main reasons I invested in NTRP.
Bryo has been around for a long time, first tested for cancer. I'm not sure when it was first tested for AZD. I presume that was at BRNI, and probably by Dr Alkon. Does anyone here know when, where, and by who?
News 
Market Data 
Discover 
